Mesirow Financial Investment Management, Inc. Vaxart, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.84 Billion
- Q2 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 20,000 shares of VXRT stock, worth $7,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$7,600
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VXRT
# of Institutions
78Shares Held
12.4MCall Options Held
66.1KPut Options Held
0-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$674,2510.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$670,2750.0% of portfolio
-
State Street Corp Boston, MA851KShares$323,4250.0% of portfolio
-
Ubs Group Ag826KShares$313,7880.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...